Simoes Correa-Galendi, Julia; del Pilar Estevez Diz, Maria - In: Applied Health Economics and Health Policy 19 (2020) 1, pp. 97-109
Background: Clinical evidence supports the use of genetic counselling and BRCA1/2 testing for women at risk for hereditary breast and ovarian cancer. Currently, screen-and-treat strategies are not reimbursed in the Brazilian Unified Healthcare System (SUS). The aim of this modelling study was to...